Immunogenicity with repeated dosing of ocrelizumab in patients with multiple sclerosis

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: 91be6dde01d63693754724c805671c385163c819
First added on: Feb 07, 2025